Liki24

Liki24 is a Kyiv‑born health‑tech marketplace that aggregates pharmacies and sellers to let consumers compare prices and order medicines, supplements and health & beauty products with optimized cross‑border logistics and same‑day or next‑day delivery across multiple European and global markets[2][3].

High‑Level Overview

• Mission: Liki24 aims to make essential health products more affordable and accessible by aggregating pharmacy inventory, applying cross‑border price arbitrage and AI‑driven logistics to reduce cost and delivery time for consumers[2][3].
  - Investment philosophy / Key sectors / Impact on startup ecosystem: As a portfolio company (not an investment firm), Liki24 sits in the digital health / e‑pharmacy sector and has attracted venture funding to scale European and global operations; its growth demonstrates investor appetite for marketplaces that combine healthcare compliance with logistics and AI, and it helps validate health‑marketplace models from Eastern Europe to wider markets[2][5].
  - Product, customers and problem solved: Liki24 builds an online marketplace and mobile app that aggregates tens or hundreds of thousands of SKUs (medicines, OTC drugs, supplements, cosmetics, medical devices) from thousands of pharmacy partners so consumers can find lower prices, check stock and receive orders via local courier or pickup[1][3]. The platform addresses fragmented pharmacy availability, high cross‑border price variance and slow traditional delivery by matching products, optimizing delivery chains and offering price transparency[1][2][3].
  - Growth momentum: Liki24 has raised multiple funding rounds, expanded across European countries, reported multi‑million monthly visits and millions of users, launched a global platform serving dozens of countries and secured recent funding to accelerate Western expansion[2][5].

Origin Story

• Founding and founders: Liki24 was founded in 2017 in Kyiv by Anton Avrynskyi (CEO) and a team including Dmytro Liatambur, Serhii Fadieiev, Sergii Kliebanov and Volodymyr Zubenko[2][4].
  - How the idea emerged: The company began as a digital aggregation of local pharmacy inventory to solve availability and price fragmentation; the COVID‑19 period accelerated demand for remote access to medicines and pushed the team to scale the marketplace vision and logistics capabilities[3].
  - Early traction / pivotal moments: Early fundraising (including a €1M seed and later a €5M round led by Horizon Capital) and rapid uptake during the pandemic were inflection points; AI investments for product matching and logistics later enabled faster cross‑border delivery and international expansion[3][2].

Core Differentiators

• Marketplace scale and assortment: Aggregates large catalogs (reports cite from tens of thousands up to 200K+ SKUs across many sellers), enabling robust price comparison and choice for consumers[1][2].
  - Cross‑border price arbitrage: Uses differences in national pricing to surface savings (company claims up to ~50% savings on some products) and routes orders to lower‑cost suppliers when feasible[2].
  - AI‑driven product mapping and logistics: Machine learning matches equivalent SKUs from disparate sellers and selects multi‑segment delivery chains to reduce cost and time, improving delivery speed multiple‑fold compared with traditional carriers[3].
  - Multichannel delivery and local partner network: Combines local pharmacy inventory, couriers and pickup options to offer same‑ or next‑day fulfillment in many cities[1][3].
  - Rapid multilingual/global expansion: Launched a global platform (Liki24.global) supporting multiple languages/currencies and early traction in dozens of countries, signaling product‑market fit beyond Europe[5].

Role in the Broader Tech Landscape

• Trend alignment: Liki24 rides several converging trends — digitalization of pharmacy services, e‑commerce marketplaces, AI for product normalization and routing, and consumer demand for lower‑cost cross‑border healthcare access[3][2].
  - Why timing matters: Pandemic‑era adoption of remote health services accelerated user behavior change; rising pressure on healthcare costs in Europe and global medicine price dispersion create room for marketplaces that can legally and logistically reconcile cross‑border flows[3][2].
  - Market forces in their favor: Large, fragmented pharmacy markets across countries (variable prices and stock), improved cross‑border payments and logistics tech, and investor interest in health‑marketplace ventures support scaling opportunities[2][3].
  - Influence on ecosystem: Liki24’s model demonstrates how AI plus local partner networks can scale regulated physical‑goods marketplaces, potentially prompting incumbents and startups to invest in better product matching, logistics orchestration and cross‑border commerce capabilities[3].

Quick Take & Future Outlook

• Near term: Expect continued geographic expansion (Western Europe and global rollouts), deeper AI investments for matching/logistics, and growth of adjacent services such as lab test marketplaces and preventive health offerings that the company has started developing[5][3].
  - Medium term risks and opportunities: Opportunities include consolidating fragmented pharmacy supply, B2B advertising and partnerships with insurers or clinics; risks include regulatory complexity in medicine distribution across jurisdictions, reimbursement rules, and competition from local e‑pharmacies or large e‑commerce platforms moving into health[2][3].
  - How influence might evolve: If Liki24 maintains logistic cost advantages and regulatory compliance while scaling user trust, it could become a continental or global layer for price discovery and fulfillment of physical health products, pushing incumbents to improve pricing transparency and delivery experiences[3][5].

Quick take: Liki24 is a technology‑first e‑pharmacy marketplace from Kyiv that combines AI, a broad pharmacy network and cross‑border logistics to cut consumer costs and speed up delivery — its recent global expansion and funding signal a move from regional scale to a more ambitious international play, with regulatory navigation and competitive responses the main determinants of long‑term success[2][3][5].